中国关节病型银屑病诊疗共识(2020)

2020-08-30 中国皮肤性病相关专家小组(统称) 中华皮肤科杂志.2020,53(8):585-595.

关节病型银屑病(又称银屑病关节炎)是银屑病的一种特殊类型,表现为外周、中轴关节不同程度受累,严重影响患者的生活质量。近年来其诊疗手段有了快速的发展,特别是生物制剂的出现明显提高了其治疗效果。本共识在国

中文标题:

中国关节病型银屑病诊疗共识(2020)

发布日期:

2020-08-30

简要介绍:

关节病型银屑病(又称银屑病关节炎)是银屑病的一种特殊类型,表现为外周、中轴关节不同程度受累,严重影响患者的生活质量。近年来其诊疗手段有了快速的发展,特别是生物制剂的出现明显提高了其治疗效果。本共识在国内外最新共识及指南的基础上,结合我国的诊疗现状,重点阐述关节病型银屑病的临床表现及分型、影像学及实验室检查、诊断标准和治疗等,为临床医生的诊疗工作提供参考依据。

下载附件:

(因为版权问题,不支持下载)

评论区 (22)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1225729, encodeId=1f061225e2934, content=怎么获取?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc475462808, createdName=ms5000001255976811, createdTime=Fri Jun 10 22:31:44 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075364, encodeId=500e10e536443, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfda5424536, createdName=ms6000000872646919, createdTime=Tue Nov 30 10:23:38 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001490, encodeId=12311001490ca, content=怎么获取啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Wed Jul 21 21:01:28 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977689, encodeId=34509e7689ed, content=怎么获取啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c45535826, createdName=ms2000001803844831, createdTime=Mon Jun 28 20:16:48 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973756, encodeId=41979e375684, content=怎么获取指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a965521404, createdName=ms3000000571710887, createdTime=Tue Jun 15 16:18:20 CST 2021, time=2021-06-15, status=1, ipAttribution=)]
    2022-06-10 ms5000001255976811

    怎么获取?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1225729, encodeId=1f061225e2934, content=怎么获取?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc475462808, createdName=ms5000001255976811, createdTime=Fri Jun 10 22:31:44 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075364, encodeId=500e10e536443, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfda5424536, createdName=ms6000000872646919, createdTime=Tue Nov 30 10:23:38 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001490, encodeId=12311001490ca, content=怎么获取啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Wed Jul 21 21:01:28 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977689, encodeId=34509e7689ed, content=怎么获取啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c45535826, createdName=ms2000001803844831, createdTime=Mon Jun 28 20:16:48 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973756, encodeId=41979e375684, content=怎么获取指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a965521404, createdName=ms3000000571710887, createdTime=Tue Jun 15 16:18:20 CST 2021, time=2021-06-15, status=1, ipAttribution=)]
    2021-11-30 ms6000000872646919

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1225729, encodeId=1f061225e2934, content=怎么获取?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc475462808, createdName=ms5000001255976811, createdTime=Fri Jun 10 22:31:44 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075364, encodeId=500e10e536443, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfda5424536, createdName=ms6000000872646919, createdTime=Tue Nov 30 10:23:38 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001490, encodeId=12311001490ca, content=怎么获取啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Wed Jul 21 21:01:28 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977689, encodeId=34509e7689ed, content=怎么获取啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c45535826, createdName=ms2000001803844831, createdTime=Mon Jun 28 20:16:48 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973756, encodeId=41979e375684, content=怎么获取指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a965521404, createdName=ms3000000571710887, createdTime=Tue Jun 15 16:18:20 CST 2021, time=2021-06-15, status=1, ipAttribution=)]
    2021-07-21 美尼尔

    怎么获取啊

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1225729, encodeId=1f061225e2934, content=怎么获取?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc475462808, createdName=ms5000001255976811, createdTime=Fri Jun 10 22:31:44 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075364, encodeId=500e10e536443, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfda5424536, createdName=ms6000000872646919, createdTime=Tue Nov 30 10:23:38 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001490, encodeId=12311001490ca, content=怎么获取啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Wed Jul 21 21:01:28 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977689, encodeId=34509e7689ed, content=怎么获取啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c45535826, createdName=ms2000001803844831, createdTime=Mon Jun 28 20:16:48 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973756, encodeId=41979e375684, content=怎么获取指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a965521404, createdName=ms3000000571710887, createdTime=Tue Jun 15 16:18:20 CST 2021, time=2021-06-15, status=1, ipAttribution=)]
    2021-06-28 ms2000001803844831

    怎么获取啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1225729, encodeId=1f061225e2934, content=怎么获取?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc475462808, createdName=ms5000001255976811, createdTime=Fri Jun 10 22:31:44 CST 2022, time=2022-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075364, encodeId=500e10e536443, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfda5424536, createdName=ms6000000872646919, createdTime=Tue Nov 30 10:23:38 CST 2021, time=2021-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001490, encodeId=12311001490ca, content=怎么获取啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210509/afbaf47f8410484296e20353a49380c3/71b4a3ef39464967b21183f90434c121.jpg, createdBy=a04b5145063, createdName=美尼尔, createdTime=Wed Jul 21 21:01:28 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977689, encodeId=34509e7689ed, content=怎么获取啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00c45535826, createdName=ms2000001803844831, createdTime=Mon Jun 28 20:16:48 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973756, encodeId=41979e375684, content=怎么获取指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a965521404, createdName=ms3000000571710887, createdTime=Tue Jun 15 16:18:20 CST 2021, time=2021-06-15, status=1, ipAttribution=)]
    2021-06-15 ms3000000571710887

    怎么获取指南

    0

拓展阅读

2010 银屑病关节炎诊断及治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2010-09-01

2011 EULAR共识:银屑病关节炎的药物治疗

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2011-09-27

2012 寻常性银屑病的常用外用药物治疗共识

中华医学会皮肤性病学分会 · 2012-04-30

2012 BSR/BHPR指南:应用生物制剂治疗银屑病关节炎

英国风湿病学会(BSR,British Society for Rheumatology) · 2013-07-25